BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2769957)

  • 1. [Essential thrombocythemia with Philadelphia chromosome].
    Yoshimura Y; Nakayama A; Oguchi J; Matsuda J; Kamakura M; Kinoshita T; Kazama M; Yamanaka M; Kida I; Abe T
    Rinsho Ketsueki; 1989 Mar; 30(3):332-7. PubMed ID: 2769957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic myelogenous leukemia with marked thrombocytosis--comparison with essential thrombocythemia with Ph1 in its megakaryokinetics].
    Kojima H; Hasegawa Y; Ikegami T; Nagasawa T; Abe T
    Rinsho Ketsueki; 1990 Jan; 31(1):35-40. PubMed ID: 2313904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Philadelphia-chromosome positive essential thrombocythemia. Two cases in children.
    Kastan MB; Zehnbauer BA; Leventhal BG; Corden BJ; Dover GJ
    Am J Pediatr Hematol Oncol; 1989; 11(4):433-6. PubMed ID: 2618978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia.
    Michiels JJ; Berneman Z; Schroyens W; Kutti J; Swolin B; Ridell B; Fernando P; Zanetto U
    Ann Hematol; 2004 Aug; 83(8):504-12. PubMed ID: 15164229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Every case of essential thrombocythemia should be tested for the Philadelphia chromosome.
    Rice L; Popat U
    Am J Hematol; 2005 Jan; 78(1):71-3. PubMed ID: 15609281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombocytosis in a Ph1 positive chronic myeloproliferative syndrome. Chronic myeloid leukemia or essential thrombocythemia].
    López L; Alonso F; Pascual T
    Sangre (Barc); 1992 Aug; 37(4):299. PubMed ID: 1514146
    [No Abstract]   [Full Text] [Related]  

  • 7. Philadelphia chromosome positive essential thrombocythemia with dilated cardiomyopathy.
    Khandakar MR; Roy K; Mukherjee S; Talukdar A
    J Assoc Physicians India; 2005 Jun; 53():568-70. PubMed ID: 16121816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the breakpoint cluster region in essential thrombocythemia.
    Corradini P; Palumbo AP; Battaglio S; Ponzio G; Boccadoro M; Pileri A
    Haematologica; 1990; 75(6):573-5. PubMed ID: 2098301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sideroblastic anemia preceded by essential thrombocythemia with 20q- chromosome abnormality].
    Yamada K; Nakamaki T; Yokoyama A; Hino K; Tomoyasu S; Sakurai M; Tsuruoka N
    Rinsho Ketsueki; 1993 Sep; 34(9):1027-32. PubMed ID: 8230746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Philadelphia translocation and pre-existing myeloproliferative disorders.
    Curtin NJ; Campbell PJ; Green AR
    Br J Haematol; 2005 Mar; 128(5):734-6. PubMed ID: 15725099
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms.
    Vannucchi AM; Masala G; Antonioli E; Chiara Susini M; Guglielmelli P; Pieri L; Maggi L; Caini S; Palli D; Bogani C; Ponziani V; Pancrazzi A; Annunziato F; Bosi A
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2068-73. PubMed ID: 19531676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Philadelphia chromosome-positive thrombocythemia and megakaryoblast leukemia.
    Michiels JJ; Prins ME; Hagermeijer A; Brederoo P; van der Meulen J; van Vliet HH; Abels J
    Am J Clin Pathol; 1987 Nov; 88(5):645-52. PubMed ID: 3479003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An XXX female with essential thrombocythemia].
    Ohta T; Hagiwara K; Makita K; Mugitani A; Ohta K; Yamane T; Takubo T; Hino M
    Rinsho Ketsueki; 2003 Jul; 44(7):477-9. PubMed ID: 12931569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAP negative and Ph1-positive hemorrhagic thrombocythemia.
    Butoianu E; Colită A; Nicoară S; Ursea C; Berceanu S
    Med Interne; 1977; 15(1):63-5. PubMed ID: 557234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential thrombocythemia with deleted 5q--a genetic and morphologic hybrid?
    Wong KF; Yu PH; Wong WS
    Cancer Genet Cytogenet; 2010 Aug; 201(1):39-41. PubMed ID: 20633767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential thrombocythemia in a child with elevated thrombopoietin concentrations and skeletal anomalies.
    Robins EB; Niazi M
    Pediatr Blood Cancer; 2008 Apr; 50(4):859-61. PubMed ID: 17455310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome.
    Stoll DB; Peterson P; Exten R; Laszlo J; Pisciotta AV; Ellis JT; White P; Vaidya K; Bozdech M; Murphy S
    Am J Hematol; 1988 Feb; 27(2):77-83. PubMed ID: 3422539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is very high platelet count always associated with essential thrombocythemia? An unusual presentation in a child.
    Aktekin EH; Yazici N; Kozanoğlu İ; Erbay A
    Lab Med; 2023 Nov; 54(6):e170-e176. PubMed ID: 37352366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic findings in untreated patients with essential thrombocythemia.
    Panani AD
    In Vivo; 2006; 20(3):381-4. PubMed ID: 16724675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
    Pikman Y; Levine RL
    Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.